U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951880) titled 'A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers' on April 23.

Brief Summary: The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.

Study Start Date: June 27

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: AZD4916

AZD4916 will be administered as oral solution.

OTHER: Placebo

Placebo will be administered as oral solution.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....